Earlier this week, a unit of New Jersey-based Johnson & Johnson announced that it planned to discontinue sales of its vaginal mesh implants. The company denies that the decision was made in response to the product liability lawsuits that have been filed in connection with the mesh, but that the "negative overall publicity about vaginal mesh devices" motivated the discontinuation.
Earlier this week, we began a look at common issues with the FDA's approval process which have resulted in unsafe medical devices being approved for sale and use by patients in New Jersey and throughout the country and world. As a result, many patients who have received these medical products have reported adverse side effects including debilitating pain, injury and even death.
Slow and steady seems to be the name of the game in the main personal injury lawsuit against DePuy Orthopaedics, a division of New Jersey company Johnson & Johnson, over its faulty artificial hip replacement products.
According to a recently released document, New Jersey company Johnson & Johnson began taking action to phase out the use of its metal-on-metal artificial hips just weeks after the receiving a letter from U.S. Food and Drug Administration. In that letter, the agency reportedly turned down Johnson's application to sell the medical product in the United States, and told the company to submit additional safety data if it wanted to pursue the application.
After a string of product recalls and products liability lawsuits, the chief executive officer of Johnson & Johnson is reportedly stepping down from his position later this spring. Although the New Jersey company's revenue has doubled in the past decade, the many product recalls in recent years have reportedly cost Johnson & Johnson more than $1 billion, as well as the serious hits to its public image and consumers' trust.
Last week, we wrote that the U.S. Food and Drug Administration had ordered additional research into the vaginal mesh products that have caused injury and even death to women throughout the country.
Earlier this week, we wrote about the recent influx of product liability lawsuits against New Jersey-based Johnson & Johnson regarding its vaginal mesh implant products, which have resulted in injury and death in hundreds of women throughout the country. The vaginal mesh suits are not the only litigation facing Johnson & Johnson at this time. The company is also defending itself against a growing class action products liability lawsuit after "mechanical failure" forced the recall of hundreds of artificial joints.
Later this week, the U.S. Senate Commerce Committee is scheduled to hear a bill which, if passed, will significantly increase the potential fines to automakers who delay automobile recalls for any reason. The bill also aims to toughen safety requirements for car manufacturers and commercial bus companies in the wake of several fatal car and bus accidents that have taken place in recent months.
Recently, the J.M. Smucker Co. announced that it was instituting a recall of more than 3,000 jars of its Smucker's Natural Peanut Butter Chunky product amidst concerns that the peanut butter was tainted with salmonella. If consumed, the salmonella bacteria found in unsafe foods causes fever, cramps, and diarrhea which can persist for several days and lead to hospitalization, lasting injury and death. Smucker claims that it has received no reports of illnesses as a result of the salmonella contamination.
Honda recently announced a worldwide recall of more than 1 million cars from two model lines in order to fix potential electrical problems and a software malfunctions in the vehicles. The recall is the second of its kind in a month: in early August, the automaker recalled about 1.5 million vehicles after learning of design defects in the vehicles' transmissions.